Evaxion Biotech (EVAX) Tops Q2 EPS by 10c

Evaxion Biotech (NASDAQ: EVAX) reported Q2 EPS of ($0.20), $0.10 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Evaxion Biotech (EVAX) click here.

You May Also Be Interested In

• Charles Schwab (SCHW) EPS edges past estimates, revenue up sequentially but dips YoY
• Orgenesis (ORGS) Issues Year End Business Update
• Cryo-Cell International, Inc. (CCEL) Tops Q1 EPS by 9c